Adhesive capsulitis of the shoulder — DVA SoP factors

Reasonable Hypothesis (RH) — Statement of Principles No. 72 of 2020

At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting adhesive capsulitis of the shoulder or death from adhesive capsulitis of the shoulder with the circumstances of a person's relevant service:

1. (1)
   having a significant injury involving the arm or shoulder of the affected side within the six months before the clinical onset of adhesive capsulitis of the shoulder;

   Note: significant injury involving the arm or shoulder is defined in the Schedule 1 - Dictionary.

2. (2)
   undergoing a surgical procedure involving the shoulder, chest wall or neck of the affected side within the six months before the clinical onset of adhesive capsulitis of the shoulder;
3. (3)
   having paralysis of the affected shoulder within the one year before the clinical onset of adhesive capsulitis of the shoulder;
4. (4)
   having rotator cuff syndrome of the affected side at the time of the clinical onset of adhesive capsulitis of the shoulder;
5. (5)
   having a malignant neoplasm involving the region of the affected shoulder or the adjacent thoracic region, including the breast, within the one year before the clinical onset of adhesive capsulitis of the shoulder;
6. (6)
   having diabetes mellitus at the time of the clinical onset of adhesive capsulitis of the shoulder;
7. (7)
   having a thyroid disease from the specified list of thyroid diseases at the time of the clinical onset of adhesive capsulitis of the shoulder;

   Note: specified list of thyroid diseases is defined in the Schedule 1 - Dictionary.

8. (8)
   having Parkinson's disease at the time of the clinical onset of adhesive capsulitis of the shoulder;
9. (9)
   having dyslipidaemia before the clinical onset of adhesive capsulitis of the shoulder;

   Note: dyslipidaemia is defined in the Schedule 1 - Dictionary.

10. (10)
    taking highly active antiretroviral therapy for human immunodeficiency virus infection at the time of the clinical onset of adhesive capsulitis of the shoulder;
11. (11)
    taking phenobarbital or primidone within the six weeks before the clinical onset of adhesive capsulitis of the shoulder;

    Note: Phenobarbital is also known as phenobarbitone.

12. (12)
    having a significant injury involving the arm or shoulder of the affected side within the six months before the clinical worsening of adhesive capsulitis of the shoulder;

    Note: significant injury involving the arm or shoulder is defined in the Schedule 1 - Dictionary.

13. (13)
    undergoing a surgical procedure involving the shoulder, chest wall or neck of the affected side within the six months before the clinical worsening of adhesive capsulitis of the shoulder;
14. (14)
    having paralysis of the affected shoulder within the one year before the clinical worsening of adhesive capsulitis of the shoulder;
15. (15)
    having rotator cuff syndrome of the affected side at the time of the clinical worsening of adhesive capsulitis of the shoulder;
16. (16)
    having a malignant neoplasm involving the region of the affected shoulder or the adjacent thoracic region, including the breast, within the one year before the clinical worsening of adhesive capsulitis of the shoulder;
17. (17)
    having diabetes mellitus at the time of the clinical worsening of adhesive capsulitis of the shoulder;
18. (18)
    having a thyroid disease from the specified list of thyroid diseases at the time of the clinical worsening of adhesive capsulitis of the shoulder;

    Note: specified list of thyroid diseases is defined in the Schedule 1 - Dictionary.

19. (19)
    having Parkinson's disease at the time of the clinical worsening of adhesive capsulitis of the shoulder;
20. (20)
    having dyslipidaemia before the clinical worsening of adhesive capsulitis of the shoulder;

    Note: dyslipidaemia is defined in the Schedule 1 - Dictionary.

21. (21)
    taking highly active antiretroviral therapy for human immunodeficiency virus infection at the time of the clinical worsening of adhesive capsulitis of the shoulder;
22. (22)
    taking phenobarbital or primidone within the six weeks before the clinical worsening of adhesive capsulitis of the shoulder;

    Note: Phenobarbital is also known as phenobarbitone.

23. (23)
    inability to obtain appropriate clinical management for adhesive capsulitis of the shoulder;

Aggravation-only factors: the factors in subsections 9(12) to 9(23) apply only to material contribution to, or aggravation of, the condition where it was suffered or contracted before or during (but did not arise out of) the person’s relevant service.